NCT02275533 2026-05-28Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting82 enrolled 13 charts